Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Cancer Prev Res (Phila). 2013 Nov 11;7(2):186–198. doi: 10.1158/1940-6207.CAPR-13-0276

Figure 3. Erb-041 treatment enhances expression of ERβ.

Figure 3

(A) immunostaining of ERβ in human normal, tumor-adjacent and SCC/skin; (B) immunostaining showing nuclear and cytoplasmic expression of ERβ (C) mRNA expression (semi-quantitative PCR) of ERβ in UVB-(alone)-induced and Erb-041+UVB-induced SCCs; (D) immunocytostaining of ERβ in HaCaT, A431 and SCC13 cells treated with vehicle or Erb-041 for 24h; (E) western blot analysis showing expression of ERβ and its responsive genes p-c-Jun, SP-1 in A431 cells treated with vehicle or Erb-041.